1992
DOI: 10.1038/358507a0
|View full text |Cite
|
Sign up to set email alerts
|

Evidence for a viral superantigen in humans

Abstract: Superantigens bind class II major histocompatibility proteins and stimulate powerful proliferative responses of T lymphocytes bearing particular V beta sequences as part of their alpha beta antigen receptor. Exogenous bacterial superantigens are responsible for food poisoning and toxic shock syndrome. Murine virus-encoded self-superantigens induce clonal deletion of T lymphocytes. Although superantigen-like properties have been suggested for human immunodeficiency virus-1, no viral superantigen has been identi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
64
0
8

Year Published

1994
1994
2010
2010

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 169 publications
(73 citation statements)
references
References 27 publications
1
64
0
8
Order By: Relevance
“…The high efficacy of RV in inducing an antiviral immune response may also be due to the stimulation of immunocytes by RV components. Lafon and colleagues demonstrated that the nucleocapsid of RV acts as a viral superantigen, which activates T lymphocytes bearing particular V beta subsets of T cell receptor via its binding to major histocompatibility complex class II (2,47,48).…”
mentioning
confidence: 99%
“…The high efficacy of RV in inducing an antiviral immune response may also be due to the stimulation of immunocytes by RV components. Lafon and colleagues demonstrated that the nucleocapsid of RV acts as a viral superantigen, which activates T lymphocytes bearing particular V beta subsets of T cell receptor via its binding to major histocompatibility complex class II (2,47,48).…”
mentioning
confidence: 99%
“…Since the presentation of an MHC II-peptide complex by the B cell is unlikely [9,11], HIV-associated superantigens may contribute to T cell activation by TCR triggering [17,19,20]. However, if HIVassociated gp120 indeed acted as viral superantigen in B cell/T cell co-cultures, infection with non-opsonized virus should also lead to viral replication and p24 antigen production.…”
Section: Discussionmentioning
confidence: 99%
“…The use of a recombinant chimeric RV͞VSV would have an advantage, compared with the use of recombinant HIV-1 gp120, to display the properly folded HIV-1 envelope protein on the surface of the infected cell. In addition, repeated expression of the RV nucleoprotein, which was previously shown to be an exogenous superantigen (37,38), might help to enhance the immune response against the HIV-1 envelope. The RV N protein is an excellent immunogen and was shown to enhance the immune response against feline immunodeficiency virus, when used in combination with the feline immunodeficiency virus surface glycoproteins (39).…”
Section: Discussionmentioning
confidence: 99%